Skip to main content

Gloria Aparicio Español

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Gloria Aparicio Español

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Implementación de un proceso asistencial automatizado para el diagnóstico precoz de artritis psoriásica en pacientes con psoriásis: Proyecto multidisciplinar entre atención primaria y atención hospitalaria

IP: María Alba Erra Duran
Collaborators: Juan Jose De Agustin De Oro, Jordi Mollet Sánchez, Implementación de un proceso asistencial automatizado para el diagnóstico precoz de artritis psoriásica en pacientes con psoriás, Yolima Cossio Gil, Emmanuel Giménez García, Gloria Aparicio Español, Luis Coronel Tarancon
Funding agency: Instituto de Salud Carlos III
Funding: 57500
Reference: PI25/01718
Duration: 01/01/2026 - 31/12/2028

Caracterización de las células patogénicas del músculo y piel de pacientes con Dermatomiositis y Síndrome Antisintetasa y estudio de aplicabilidad traslacional.

IP: Ernesto Trallero Araguas
Collaborators: Albert Selva O'Callaghan, Raul Tortosa Mendez, Albert Gil Vila, Gloria Aparicio Español, Hugo Fernando Avalos Bogado
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI22/00708
Duration: 01/01/2023 - 31/12/2026

Novel therapeutic topical approach for discoid lupus cutaneous (DLE) treatment

IP: Cristina Solé Marce
Collaborators: Berta Ferrer Fábrega, Gloria Aparicio Español
Funding agency: Instituto de Salud Carlos III
Funding: 99099
Reference: PI21/01869
Duration: 01/01/2022 - 31/12/2025

Proteinas TIF1 y dermatomiositis paraneoplásicas

IP: Ernesto Trallero Araguas
Collaborators: Vicente García-Patos Briones, Berta Ferrer Fábrega, Albert Selva O'Callaghan, Gloria Aparicio Español
Funding agency: Instituto de Salud Carlos III
Funding: 121000
Reference: PI12/01320
Duration: 01/01/2013 - 31/12/2016

Related news

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

Related professionals

Montserrat García Serqueda

Montserrat García Serqueda

Research assistant
Clinical Neuroimmunology
Read more
Alba Urbano Alamo

Alba Urbano Alamo

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more
Joan Piñas Massó

Joan Piñas Massó

Head and Neck Cancer: Biomedical Research Cancer Stem cells
Read more
Jordi Mayol Traveria

Jordi Mayol Traveria

Junior researcher
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.